Binding properties of c-truncated delta opioid receptors

Acta Pharmacologica Sinica

Volumn 18, Issue 4, 1997, Pages 337-340

  Wang, Chun He ^a   Zhou, De He ^a   Chen, Jie ^a   Li, Gui Fen ^a   Pei, Gang ^b   Chi, Zhi Qiang ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Binding sites; CHO cells; Delta opioid receptors; Diprenorphine; Leucine 2 alanine enkephalin; Mutation; Radioligand assay

Indexed keywords

DELTA OPIATE RECEPTOR; DIPRENORPHINE; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE];

ANIMAL CELL; ARTICLE; BINDING COMPETITION; CARBOXY TERMINAL SEQUENCE; CHO CELL; CONTROLLED STUDY; DRUG COMPETITION; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; NONHUMAN; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

ANIMALS; BINDING SITES; CHO CELLS; CRICETINAE; DIPRENORPHINE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALIN, LEUCINE; ENKEPHALIN, LEUCINE-2-ALANINE; ENKEPHALINS; PEPTIDE FRAGMENTS; RADIOLIGAND ASSAY; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU;

EID: 0344902003     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Uhl GR, Childers S, Pasternak G. An opiate-receptor gene family reunion. Trends Neurosci 1994; 17: 89-93.
2. Kieffer BL. Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cell Mol Neurobiol 1995; 15: 615-35.
3. Goldstein A, Naidu A. Multiple opioid receptors: Ligand selectivity profiles and binding site signatures. Mol Pharmacol 1989; 36: 265-72.
4. Prézeau L, Gomeza J, Ahern S, Mary S, Galvez T, Bockaert J, et al. Changes in the carboxyl-terminal domain of metabotropic glutamate receptor 1 by alternative splicing generate receptors with differing agonist-independent activity. Mol Pharmacol 1996; 49: 422-9.
5. Nussenzveig DR, Heinflink M, Gershengorn MC. Agonist-stimulated internalization of the thyrotropin-releasing hormone receptor is dependent on two domains in the receptor carboxyl terminus. J Biol Chem 1993; 268: 2389-92.
6. 1A receptor in CHO-K1 cells. J Biol Chem 1995; 270: 207-13.
7. Hermans E, Octave JN, Maloteaux JM. Interaction of the COOH-terminal domain of the neurotensin receptor with a G protein does not control the phospholipase C activation but is involved in the agonist induced-internalization. Mol Pharmacol 1996; 49: 365-72.
8. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press, 1989.
9. Kieffer BL, Befort K, Gaveriaux-Ruff C, Hirth CG. The δ-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci USA 1992; 89: 12048-52.
10. 353, located within the COOH-terminal tail of the δ opiate receptor, is involved in receptor down-regulation. J Biol Chem 1996; 271: 4073-6.